Obesity cardiomyopathy: Diagnosis and therapeutic implications

Nature Clinical Practice Cardiovascular Medicine

Volumn 4, Issue 9, 2007, Pages 480-490

  Wong, Chiew ^a   Marwick, Thomas H ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CARVEDILOL; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; INSULIN; METFORMIN; METOPROLOL; PLACEBO; RENIN INHIBITOR; RIMONABANT; SERTRALINE; SIBUTRAMINE; TETRAHYDROLIPSTATIN;

ADRENERGIC STIMULATION; BARIATRIC SURGERY; CARDIOMYOPATHY; CLINICAL EXAMINATION; CLINICAL FEATURE; CLINICAL TRIAL; COMORBIDITY; DIABETES MELLITUS; DIAGNOSTIC VALUE; DIET THERAPY; DOPPLER ECHOCARDIOGRAPHY; DRUG MECHANISM; EARLY INTERVENTION; EXERCISE; EXERCISE TEST; FLUID RETENTION; FOLLOW UP; HEART CONTRACTION; HEART HEMODYNAMICS; HEART LEFT VENTRICLE FAILURE; HEART VENTRICLE REMODELING; HEART VENTRICULOGRAPHY; HUMAN; INSULIN RESISTANCE; LIFESTYLE MODIFICATION; LIPOSUCTION; METABOLIC ACIDOSIS; MULTIDETECTOR COMPUTED TOMOGRAPHY; NON INVASIVE PROCEDURE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN DETERMINATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SENSITIVITY AND SPECIFICITY; SIDE EFFECT; STRESS ECHOCARDIOGRAPHY; TWO DIMENSIONAL ECHOCARDIOGRAPHY; VASCULAR DISEASE; WEIGHT CONTROL; WEIGHT REDUCTION;

ANIMALS; ANTI-OBESITY AGENTS; BARIATRIC SURGERY; CARDIOMYOPATHIES; HEART FAILURE, CONGESTIVE; HUMANS; NATRIURETIC PEPTIDE, BRAIN; OBESITY; RENIN-ANGIOTENSIN SYSTEM; SYMPATHETIC NERVOUS SYSTEM; VENTRICULAR DYSFUNCTION, LEFT; WEIGHT LOSS;

EID: 34548216360     PISSN: 17434297     EISSN: 17434300     Source Type: Journal    
DOI: 10.1038/ncpcardio0964     Document Type: Review

References (63)

1. Hunt SA et al. (2005) ACC/AHA 2005 Guideline update for the diagnosis and management of chronic heart failure in the adult - summary article: A report of the American College of Cardiology/American Heart Association Task Force Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Manage nent of Heart Failure). J Am Coll Cardiol 46: 1116-1143
2. Swedberg K et al. (2006) Guidelines for the diagnosis and treatment of chronic heart failure - executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 26: 1115-1140
3. McDonagh TA et al. (1997) Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population. Lancet 350: 829-833
4. Dewey M et al. (2006) Evaluation of global and regional left veniricular function with 16-slice computed tomography, biplane cineventriculography, and two-dimensional transthoracic echocardiography: Comparison with magnetic resonance imaging. J Am Coll Cardiol 48: 2034-2044.
5. Danias PG et al. (2003) Cardiac structure and function in the obese: A cardiovascular magnetic resonance imaging study. J Cardiovasc Magn Reson 5: 431-438
6. Vasan RS et al. (1997) Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction. N Engl J Med 336: 1350-1355
7. Wang TJ et al. (2003) The epidemiology of "asymptomatic" left ventricular systolic dysfunction: Implications for screening. Ann Intern Med 138: 907-916
8. Garcia MJ et al. (1998) New Doppler echocardiographic applications for the study of diastolic function. J Am Coll Cardiol 32: 865-875
9. Wong CY et al. (2004) Alterations of left ventricular myocardial characteristics associated with obesity. Circulation 110: 3081-3087
10. Wong CY et al. (2006) Association of subclinical right ventricular dysfunction with obesity. J Am Coll Cardiol 47: 611-616
11. Marwick TH (2004) Should we be evaluating the ventricle or the myocardium? Advances in tissue characterization. J Am Soc Echocardiogr 17: 168-172
12. 2. Am J Cardiol 98: 1593-1598
13. Alpert MA et al. (1989) Effect of exercise and cavity size on right ventricular function in morbid obesity. Am J Cardiol 64 1361-1365
14. Alaud-din A et al. (1990) Assessment of cardiac function in patients who were morbidly obese. Surgery 108: 809-818
15. Laukkanen JA et al. (2004) The predictive value of cardiorespiratory fitness for cardiovascular events in men with various risk profiles: A prospective population-based cohort study. Eur Heart J 25: 1428-1437
16. Wang TJ et al. (2004) Impact of obesity on plasma natriuretic peptide levels. Circulation 109: 594-600
17. Taylor JA et al. (2006) B-type natriuretic peptide and N-terminal pro B-type natriuretic peptide are depressed in obesity despite higher left ventricular end diastolic pressures. Am Heart J 152: 1071-1076
18. Wong CY and Marwick TH (2007) Obesity cardiomyopathy: Pathogenesis and pathophysiology. Nat Clin Pract Cardiovasc Med 4: 436-443
19. Mertens IL and Van Gaal LF (2000) Overweight, obesity, and blood pressure: The effects of modest weight reduction. Obes Res 8 270-278
20. Tuomilehto J et al. (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344: 1343-1350
21. Keenan KP et al. (2005) Diabesity: A polygenic model of dietary-induced obesity from ad libitum overfeeding of sprague-dawley rats and its modulation by moderate and marked dietary restriction. Toxicol Pathol 33: 650-674
22. MacMahon SW et al. (1986) The effect of weight reduction on left ventricular mass: A randomized controlled trial in young, overweight hypertensive patients. N Engl J Med 314: 334-339
23. Marfella R et al. (2004) Effect of weight loss on cardiac synchronization and proinflammatory cytokines in premenopausal obese women. Diabetes Care 27: 47-52
24. DasGupta P et al. (1992) Improvement in left ventricular function after rapid weight loss in obesity. Eur Heart J 13: 1060-1066
25. Corrao S et al. (2000) Effects of a short-term hypoenergetic diet on morphofunctional left ventricular parameters in centrally obese subjects: An echocardiographic study. Panminerva Med 42: 123-129
26. Willens HJ et al. (2005) Effects of weight loss after gastric bypass on right and left ventricular function assessed by tissue Doppler imaging. Am J Cardiol 95: 1521-1524
27. Todaka K et al. (1997) Impact of exercise training on ventricular properties in a canine model of congestive heart failure. Am J Physiol 272: H1382-H1390
28. Belardinelli R et al. (1995) Exercise training improves left ventricular diastolic filling in patients with dilated cardiomyopathy: clinical and prognostic implications. Circulation 91: 2775-2784
29. Wirth A and Kroger H (1995) Improvement of left ventricular morphology and function in obese subjects following a diet and exercise program. Int J Obes Relat Metab Disord 19: 61-66
30. Hinderliter A et al (2002) Reduction of left ventricular hypertrophy after exercise and weight loss in overweight patients with mild hypertension. Arch Intern Med 162: 1333-1339
31. Ploug T et al. (1998) Analysis of GLUT4 distribution in whole skeletal muscle fibers: Identification of distinct storage compartments that are recruited by insulin and muscle contractions. J Cell Biol 142: 1429-1446
32. James WP et al. (2000) Effect of sibutramine on weight maintenance after weight loss: A randomised trial. STORM Study Group. Sibutramine Trial of Obesity Reduction and Maintenance. Lancet 356: 2119-2125
33. Jordan J et al. (1995) Reduction of weight and left ventricular mass with serotonin uptake inhibition in obese patients with systemic hypertension. Am J Cardiol 75: 743-744
34. Godoy-Matos A et al. (2005) Treatment of obese adolescents with sibutramine: A randomized, double-blind, controlled study. J Clin Endocrinol Metab 90: 1460-1465
35. Alexander JK and Peterson KL (1972) Cardiovascular effects of weight reduction. Circulation 45: 310-318
36. Alpert MA et al. (1995) Effect of weight loss on left ventricular diastolic filling in morbid obesity. Am J Cardiol 76: 1198-1201
37. Sjostrom CD et al. (1999) Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: The SOS Intervention Study. Obes Res 7: 477-484
38. Karason K et al. (1997) Effects of obesity and weight loss on left ventricular mass and relative wall thickness: Survey and intervention study. BMJ 315: 912-916
39. Alpert MA et al. (1985) Effect of weight loss on cardiac chamber size, wall thickness and left ventricular function in morbid obesity. Am J Cardiol 55: 783-786
40. Alpert MA et al. (1994) Effect of weight loss on left ventricular mass in nonhypertensive morbidly obese patients. Am J Cardiol 73: 918-921
41. Alpert MA et al. (1993) Factors influencing left ventricular systolic function in nonhypertensive morbidly obese patients, and effect of weight loss induced by gastroplasty. Am J Cardiol 71: 733-737
42. Kanoupakis E et al. (2001) Left ventricular function and cardiopulmonary performance following surgical treatment of morbid obesity. Obes Surg 11: 552-558
43. Karason K et al. (2000) Relief of cardiorespiratory symptoms and increased physical activity after surgically induced weight loss: results from the Swedish Obese Subjects study. Arch Intern Med 160: 1797-1802
44. Alpert MA et al. (1995) Relation of duration of morbid obesity to left ventricular mass, systolic function, and diastolic filling, and effect of weight loss. Am J Cardiol 76: 1194-1197
45. Licata G et al. (1992) Left ventricular function response to exercise in normotensive obese subjects: Influence of degree and duration of obesity. Int J Cardiol 37: 223-230
46. Alpert MA et al. (1997) Cardiac morphology and left ventricular function in normotensive morbidly obese patients with and without congestive heart failure, and effect of weight loss. Am J Cardiol 80: 736-740
47. Klein S et al. (2004) Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. N Engl J Med 350: 2549-2557
48. Himeno E et al. (1996) Weight reduction regresses left ventricular mass regardless of blood pressure level in obese subjects. Am Heart J 131: 313-319
49. Tuck ML et al (1981) The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients. N Engl J Med 304: 930-933
50. Greenberg B et al. (1995) Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction: Results of the SOLVD echocardiography substudy. Circulation 91: 2573-2581
51. Vuorinen-Markkola H and Yki-Jarvinen H (1995) Antihypertensive therapy with enalapril improves glucose storage and insulin sensitivity in hypertensive patients with non-insulin-dependent diabetes mellitus. Metabolism 44: 85-89
52. Henriksen EJ et al. (1999) ACE inhibition and glucose transport in insulin resistant muscle: Roles of bradykinin and nitric oxide. Am J Physiol 277: R332-R336
53. Feuerstein GZ et al. (1997) Protective effects of carvedilol in the myocardium. Am J Cardiol 80: 41L-45L
54. Panchal AR et al. (1998) Beta-receptor blockade decreases carnitine palmitoyl transferase I activity in dogs with heart failure. J Card Fail 4: 121-126
55. Sharma AM et al. (2001) Hypothesis: Beta-adrenergic receptor blockers and weight gain: A systematic analysis. Hypertension 37: 250-254
56. Poole-Wilson PA et al. (2003) Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): Randomised controlled trial. Lancet 362: 7-13
57. AI Hesayen A et al. (2005) Selective versus nonselective beta-adrenergic receptor blockade in chronic heart failure: Differential effects on myocardial energy substrate utilization. Eur J Heart Fail 7: 618-623
58. Zhou YT et al. (2000) Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci USA 97: 1784-1789
59. Golfman LS et al. (2005) Activation of PPARgamma enhances myocardial glucose oxidation and improves contractile function in isolated working hearts of ZDF rats. Am J Physiol Endocrinol Metab 289: E328-E336
60. Raji A et al. (2003) Rosiglitazone improves insulin sensitivity and lowers blood pressure in hypertensive patients. Diabetes Care 26: 172-178
61. Wang TD et al. (2004) Effects of rosiglitazone on endothelial function, C-reactive protein, and components of the metabolic syndrome in nondiabetic patients with the metabolic syndrome. Am J Cardiol 93: 362-365
62. Ren J et al. (1999) Metformin but not glyburide prevents high glucose-induced abnormalities in relaxation and intracellular Ca2+ transients in adult rat ventricular myocytes. Diabetes 48: 2059-2065
63. Dutta K et al. (2001) Cardiomyocyte dysfunction in sucrose-fed rats is associated with insulin resistance. Diabetes 50: 1186-1192